Currently out of the existing stock ratings of Andy Chen, 33 are a BUY (73.33%), 2 are a SELL (4.44%), 10 are a HOLD (22.22%).
Analyst Andy Chen, currently employed at WOLFE, has had 72.22% of price targets met with an average potential upside of 47.29%, reached in 217 days on average.
Andy Chen has documented 76 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 12-Oct-2026.
Analyst best performing recommendations are on ALPN (ALPINE IMMUNE SCIENCES).
The best stock recommendation documented was for ALPN (ALPINE IMMUNE SCIENCES) on 10/16/2023. The price target of $18 was fulfilled within 58 days with a profit of $8 (80%), with a performance score of 13.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Jan-2026
$33
$1.23 (3.87%)
$30
11 days ago
(10-Nov-2026)
8/10 (80%)
$-2.71 (-7.59%)
239
Buy Since 24-Jul-2023
$47
$15.23 (47.94%)
$45
11 days ago
(10-Nov-2026)
8/13 (61.54%)
$11.29 (31.62%)
365
Buy Since 20-Feb-2024
$50
$18.23 (57.38%)
$35
3 months 17 days ago
(04-Aug-2026)
4/7 (57.14%)
$10.64 (27.03%)
207
Buy Since 25-Apr-2023
$61
$29.23 (92.01%)
$58
4 months 22 days ago
(30-Jun-2026)
2/8 (25%)
$22.47 (58.32%)
100
Buy Since 23-May-2023
$62
$30.23 (95.15%)
$44
5 months 26 days ago
(26-May-2026)
6/11 (54.55%)
$28.17 (83.27%)
217
Which stock is Andy Chen most bullish on?
Which stock is Andy Chen most reserved on?
What Year was the first public recommendation made by Andy Chen?